The Omega-3 Index measures the percentage of EPA and DHA in red blood cell membranes, reflecting long-term omega-3 status. It's more stable and clinically meaningful than serum omega-3 testing, which reflects recent intake.
The Omega-3 Index is one of the strongest mortality predictors in longevity literature. Values above 8% are associated with substantially lower all-cause mortality compared to below 4%. Most modern populations run well below optimal because diets emphasize omega-6 over omega-3 fats. Fatty fish (salmon, sardines, mackerel) 2-3 times weekly, or fish oil/algae oil supplementation, typically raises levels toward the target. The longevity consensus targets ≥8%, with 6-8% as acceptable and below 4% as deficient.
Optimal Omega-3 Index: 8-12 %.
Typically re-tested every 12 weeks.
FitScript's optimal range is 8 to 12 %, an optimization target rather than a diagnostic cut-off. A low result does not name a disease. It describes a nutritional status that is associated with cardiovascular and cognitive risk markers, and it is one of the few blood measures that moves predictably with what you eat.
The omega-3 index is the amount of eicosapentaenoic acid (EPA) plus docosahexaenoic acid (DHA) in red blood cell membranes, expressed as a percentage of the total fatty acids measured in that sample.
The mechanism behind the number is simple membrane chemistry. Every cell in your body is wrapped in a phospholipid membrane, and the fatty acids you absorb from food get built into those membranes. Red blood cells live for roughly four months and cannot remodel themselves the way liver or fat tissue can, so their fatty acid composition drifts slowly and averages out short-term swings in diet. That is why a result from an omega-3 index lab test is treated as a status marker rather than a snapshot.
What sits in the membrane matters beyond structure. EPA and DHA alter membrane fluidity, influence how receptors and ion channels behave, and serve as the raw material for signalling molecules involved in resolving inflammation. Research on vascular tissue suggests these fatty acids dampen inflammatory signalling in the artery wall, which is one proposed explanation for the cardiovascular associations seen in population data 1.
Measurement is usually done by gas chromatography on either a venous draw or a dried blood spot. Some providers sell a broader fatty acid profile under names like omega-3 index plus test or omega-3 index complete test, which report the same EPA plus DHA percentage alongside extras such as the omega-6 to omega-3 ratio, the arachidonic acid to EPA ratio, and trans fat fractions. The core number is the same; the add-ons give context rather than replacing it.
It matters because marine omega-3 status is one of the few modifiable nutritional markers with cardiovascular, metabolic and cognitive relevance, though its effect on outcomes is not settled and worth reading honestly.
On heart health, the picture is nuanced. A large Cochrane review of randomised trials concluded that increasing long chain omega-3 intake probably makes little or no difference to all cause mortality or overall cardiovascular events, while possibly slightly reducing coronary heart disease events and mortality, and reliably lowering triglycerides 2. Observational work points in a more favourable direction for blood levels specifically. One cohort study of people after an acute myocardial infarction found that higher circulating omega-3 levels at the time of the event were associated with fewer subsequent adverse outcomes 3. Reviews of the broader literature describe plausible mechanisms spanning triglyceride handling, platelet behaviour, heart rhythm and endothelial function 4.
For the brain, prospective cohort evidence suggests that higher dietary intake and higher blood markers of omega-3 are associated with a lower risk of dementia and slower cognitive decline, while results from supplementation trials have been less consistent 5. In pregnancy, a meta-analysis of prenatal supplementation studies examined effects on offspring cognitive outcomes and reported modest and inconsistent findings, which is a reminder that a nutrient with a strong biological rationale does not always produce a clean trial result 6.
Metabolically, a meta-analysis of randomised trials of marine omega-3 in people with features of metabolic syndrome reported improvements in several cardiometabolic measures, with triglycerides the most consistent 7. Blood pressure has also been studied directly, including a randomised trial examining whether omega-3 supplementation could help prevent hypertension 8. A review of nutritional deficiencies in women after menopause grouped omega-3 fatty acids with the micronutrients most often found lacking in that group 9.
The boundaries matter as much as the benefits. In people with intermittent claudication, a Cochrane review found no convincing evidence that omega-3 supplementation improves walking distance or symptoms 10, and a separate Cochrane review in people with cystic fibrosis concluded the available evidence was too limited to draw firm conclusions 11. A good omega-3 index is a marker of nutritional status, not a shortcut around cardiovascular risk management.
A result between 6 and 12 % sits inside the typical lab reference range, and FitScript regards 8 to 12 % as the optimal band.
| Marker | Typical lab reference range | FitScript optimal range |
|---|---|---|
| Omega-3 Index (EPA + DHA, % of red blood cell fatty acids) | 6 to 12 % | 8 to 12 % |
Reference ranges vary by lab, by method and by population, and can differ with age and sex, so always read your number against the range printed on your own report. FitScript's optimal range is an optimization target, not a diagnostic cut-off, and a value outside it does not identify a condition on its own.
Two practical notes. First, dried blood spot and venous methods are not always directly interchangeable, so comparing a result from one provider against a range from another can be misleading. Second, trends are more informative than single values here. Because membrane composition shifts over months, two results taken a season apart tell you far more about your trajectory than one result ever will.
A result at or above the top of the standard range usually reflects a high and sustained intake of marine omega-3, not a disease process.
People with high intakes sometimes report a fishy aftertaste or repeating, mild nausea or loose stools, and occasionally easier bruising or slightly longer bleeding from small cuts. These reports are subjective and non-specific, and none of them identify a problem on their own.
The common causes are straightforward. Frequent oily fish consumption, consistent supplement use, concentrated supplement formulations, and prescription omega-3 preparations all push the number up. A licensed provider evaluates whether any prescription omega-3 preparation is appropriate for a given person, and that decision sits with them, not with a test result. Genetic variation in fatty acid metabolism and differences in body size also shift where a given intake lands.
On long term impact, there is no well established upper threshold above which the omega-3 index becomes harmful, and populations with traditionally high marine diets sit comfortably at the upper end. The practical question is bleeding tendency. In people taking medication that affects blood clotting, or in anyone planning surgery, a very high intake is worth raising with a clinician promptly so it can be weighed alongside the rest of the medication list. A high result is best read as a sign that intake is generous, then checked against the rest of your lipid and inflammation picture.
A result below 6 % is outside the standard range and is generally regarded as suboptimal omega-3 status rather than a sign of any specific illness.
Most people with a low index feel nothing unusual. Some report dry skin, dry or gritty eyes, brittle nails, low mood or difficulty concentrating, but these symptoms overlap with dozens of other causes and cannot be traced back to this marker by themselves.
The usual causes are dietary and absorptive. Eating little or no oily fish is the dominant one. Relying on plant sources of alpha linolenic acid, such as flax, chia or walnuts, helps less than people expect because conversion to EPA and especially DHA in humans is limited. Inconsistent supplement use is another common reason, as is poor absorption, since omega-3 uptake depends on fat digestion and varies between formulations and delivery systems 12. Higher body weight distributes the same intake across more tissue, and pregnancy and lactation raise demand. Conditions affecting fat absorption, including bile and pancreatic insufficiency states, can lower the number too.
Over the long term, low omega-3 status is the exposure that sits behind much of the epidemiology described above. Higher blood markers have been associated with lower rates of cognitive decline in cohort studies 5, and higher circulating levels have been associated with better outcomes after cardiac events 3. Association is not causation, and intervention trials have been less uniformly positive than the observational data 2. The reasonable reading of a low result is that one modifiable input is currently low, which is worth discussing with a clinician alongside your lipids, blood pressure and family history.
More changes the result than most people assume, and almost all of it relates to intake, absorption and method rather than to the day of the draw.
Testing conditions have a smaller effect here than on most blood markers. Because the index reads membrane composition built up over months, a meal eaten shortly before sampling has little influence, and fasting is often not required. Follow whatever instructions the collecting lab gives. Sample type matters more. Dried blood spot collection depends on correct technique and on the card reaching the lab in good condition, since heat and delay can degrade the sample. Different labs also use different analytical methods and report against different ranges, so switching providers mid-way through tracking makes a trend hard to read.
Habits and physiology account for the rest. Recent changes in intake take weeks to months to appear, so a result taken shortly after starting or stopping fish or supplements will lag behind reality. Supplement chemistry matters, because absorption differs between formulations and is generally better when taken with a fat-containing meal 12. Medicines that reduce fat absorption, including orlistat and bile acid sequestrants, may lower how much omega-3 you take up from food and supplements. Smoking, heavy alcohol intake, pregnancy and lactation, higher body weight, age and sex may all influence fatty acid status. None of these are reasons to dismiss a result. They are reasons to interpret it alongside context rather than in isolation.
FitScript does not currently test the omega-3 index in any of its panels, so this marker is not part of the 150+ biomarkers tested per year.
If you already have a result from another provider, whether from a venous omega-3 index blood test or a home omega-3 index test kit, you can upload your labs so that Atlas, FitScript's AI health advisor, can read it alongside the markers that are measured. Atlas uses what it is given to build your FitScript, which is the personalized output written from your own biology rather than from population averages. An omega-3 value read next to your triglycerides, inflammatory markers and lipid ratios is far more useful than the same number read alone.
Where a result and a full clinical picture suggest that a prescription omega-3 preparation or any other therapy is worth considering, a licensed provider evaluates whether it is appropriate after reviewing the person, their medications and their history. No article, and no algorithm, makes that call. This page is educational and is not medical advice, and you should discuss your results and any treatment options with a clinician or licensed provider.
Omega-3 status is most informative as part of a cardiometabolic and inflammation cluster, because it influences and is influenced by the same pathways those markers describe.
Triglycerides is the closest partner, since lowering triglycerides is the most consistent effect of marine omega-3 across randomised trials 2. C-Reactive Protein tracks systemic inflammation, the process that omega-3 derived signalling molecules are thought to help resolve 1. Oxidized LDL reflects lipid particles that have undergone oxidative modification, which is relevant because polyunsaturated fats are themselves susceptible to oxidation. Vitamin E is the main fat soluble antioxidant carried with those lipids, so the two are often read together. Cholesterol - Total and the Cholesterol / HDL Ratio place all of this inside the wider lipid picture that cardiovascular risk assessment actually uses.
The omega-3 index tells you how much EPA and DHA your cell membranes have accumulated over the past few months. A result in FitScript's optimal band of 8 to 12 % suggests intake has been consistent and generous. A result under 6 % suggests the opposite, and is a nutritional finding rather than a diagnosis. Either way, the number is worth reading next to your lipids and inflammation markers, and worth discussing with a clinician who can see the whole picture.
Usually not. The marker reflects fatty acids built into red blood cell membranes over months, so a single meal before the draw has little effect on the result. Follow whatever preparation instructions the collecting lab provides, since some labs run the omega-3 index alongside a lipid panel that does have fasting requirements.
Months rather than days. Red blood cells live for roughly four months and are replaced gradually, so membrane composition shifts slowly after a change in diet or supplementation. Retesting too soon tends to show a partial change at best, which is why this marker is better tracked a season apart than a few weeks apart.
Dried blood spot kits can produce reliable results when the sample is collected correctly and reaches the lab in good condition, but heat, delay and poor collection technique can degrade the sample. Methods and reference ranges also differ between providers, so comparing a home result to a venous result from a different lab is not always like for like.
Those broader panels report the same EPA plus DHA percentage, then add extra fatty acid fractions such as the omega-6 to omega-3 ratio, the arachidonic acid to EPA ratio, and trans fat levels. The additions give context about overall fatty acid balance, but the core index number is unchanged and is still the figure read against reference ranges.
It is harder. Plant sources such as flax, chia and walnuts supply alpha linolenic acid, and human conversion of that into EPA and especially DHA is limited, so plant intake alone often leaves the index lower than expected. Algae-derived sources of EPA and DHA exist as an alternative, and a clinician or dietitian can advise on what fits your situation.
Not necessarily. A high value usually reflects sustained intake of oily fish or supplements rather than a problem, and populations with traditionally high marine diets sit at the upper end. In people taking medication that affects blood clotting, or anyone planning surgery, a very high intake is worth raising with a clinician promptly so it can be weighed against the rest of the medication list.
Not currently. The omega-3 index is not included in FitScript's panels, but if you already have a result from another provider you can upload your existing labs so Atlas can read it alongside your other markers when writing your FitScript.
It describes a nutritional status, not a diagnosis. A value under the standard range suggests marine omega-3 intake or absorption has been low over recent months. Lower omega-3 status is associated with cardiovascular and cognitive risk markers, though its effect on outcomes is not settled, so the result is best interpreted with a clinician alongside your lipids, blood pressure and history.
Triglycerides are the closest partner, since triglyceride lowering is the most consistent effect of marine omega-3. C-reactive protein, oxidized LDL, vitamin E, total cholesterol and the cholesterol to HDL ratio round out the inflammation and lipid context that makes an omega-3 result meaningful.